What can we learn from the NMC Health collapse?

The collapse of NMC Health has shown us that even a shining FTSE 100 champion can be rotten underneath. We can learn a few things from the scandal.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’ve seen plenty of company collapses during my years as a private investor. But it’s rare it happens to one that’s made it as far as the FTSE 100. That’s what’s happened to NMC Health (LSE: NMC), and there are lessons to be learned.

At its peak in 2018, NMC Health stock was trading at more than £40 per share. Now on Monday, the end of NMC as a listed company has come, after it requested the cancellation of its shares on the London Stock Exchange.

On 13 April, NMC Health announced it had called in the administrators, under pressure from Abu Dhabi Commercial Bank, to which it owed $1bn. That was a month after trading in the shares had been suspended, at a price of 938p. What are they worth now? I reckon almost certainly zero.

NMC Health in administration

My Motley Fool colleague Edward Sheldon has explained how a company entering administration is bad news for shareholders. The company’s creditors and bondholders are ahead in the queue. And if there’s anything left of its assets once its debts are dealt with, only then might shareholders be left with anything.

I seriously doubt there’ll be anything left, as the scale of NMC Health’s debts is truly shocking. It includes previously undisclosed debt of $4bn, for a total debt pile of more than $6.5bn.

Lesson number one

And here’s one lesson for investors. We might wonder how this can happen to a company regulated by the LSE with a FTSE 100 listing. And we might wonder if LSE auditing regulations are too lax. But the thing is, a company’s auditors are working on the company’s behalf. And unless they find anything glaring, they have to take a lot of what the company says in good faith.

The auditors aren’t being paid by the company to perform an in-depth investigation to look for wrongdoings. So don’t assume that just because a company is in the FTSE 100, its accounts must be squeaky clean.

Shorting NMC Health

It’s different for investigative investors such as Muddy Waters, which essentially pulled the plug on NMC Health in December. Back then, Muddy Waters said it believed NMC had “manipulated its balance sheet to understate debt,” having taken a short position against the firm.

And that leads me to lesson number two. A firm like Muddy Waters has to have a pretty tight case to make such potentially devastating claims. And it has a reputation for first-class investigative skills. In my view, it’s going to be very rare Muddy Waters will get something like this wrong. So the lesson I take is — if Muddy Waters says a company’s bad, run for the hills.

The signs were there

Now we know the scale of the debt understatement, Muddy Waters has been well and truly vindicated. Shareholders who heeded December’s report and sold out saved themselves from total wipeout. And, as it happens, NMC Health chairman BR Shetty and vice-chairman Khalifa Al Muhairi dumped a load of shares in January and February.

So, final lesson. When a company is up to its neck in trouble and key insiders are selling, well, I think you know the rest.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended NMC Health. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

3 value shares for investors to consider buying in 2025

Some value shares blew the roof off during 2024, so here are three promising candidates for investors to consider next…

Read more »

Investing Articles

Can this takeover news give Aviva shares the boost we’ve been waiting for?

Aviva shares barely move as news of the agreed takeover of Direct Line emerges. Shareholders might not see it as…

Read more »

Investing Articles

2 cheap FTSE 250 growth shares to consider in 2025!

These FTSE 250 shares have excellent long-term investment potential, says Royston Wild. Here's why he thinks they might also be…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

Has the 2024 Scottish Mortgage share price rise gone under the radar?

The Scottish Mortgage share price rise has meant a good year for the trust so far, but not as good…

Read more »

Investing Articles

Will the easyJet share price hit £10 in 2025?

easyJet has been trading well with rising earnings, which reflects in the elevated share price, but there may be more…

Read more »

Investing Articles

2 FTSE shares I won’t touch with a bargepole in 2025

The FTSE 100 and the FTSE 250 have some quality stocks. But there are others that Stephen Wright thinks he…

Read more »

Dividend Shares

How investing £15 a day could yield £3.4k in annual passive income

Jon Smith flags up how by accumulating regular modest amounts and investing in dividend shares, an investor can build passive…

Read more »

Investing Articles

Could this be the FTSE 100’s best bargain for 2025?

The FTSE 100 is full of cheap stocks but there’s one in particular that our writer believes has the potential…

Read more »